Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid intrauterine instillation in hysteroscopic myomectomy
IRCT20110530006640N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of tranexamic acid in Fibromyoma (LM) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Post-operative hemoglobin level. Started Mar 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20110530006640N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110530006640N8.